UK markets close in 2 hours 46 minutes

Coloplast A/S (COLO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
898.60-7.40 (-0.82%)
As of 02:44PM CEST. Market open.

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
45 49 11 11 11

IndustryMedical Instruments & Supplies
Full-time employees15,751

Key executives

NameTitlePayExercisedYear born
Mr. Kristian VillumsenPresident & CEO17.5MN/A1970
Mr. Anders Lonning-SkovgaardExecutive VP & CFO9MN/A1972
Mr. Allan RasmussenExecutive Vice President of Global Operations7.9MN/A1967
Mr. Nicolai Buhl AndersenExecutive Vice President of Innovation7.6MN/A1969
Mr. Paul MarcunExecutive Vice President of Growth9.1MN/A1967
Mr. Thomas BarfodSenior Controller & Employees Representative Director450kN/A1970
Ellen BjurgertVice President of Investor RelationsN/AN/AN/A
Dennis KaysenDirector of Corporate CommunicationsN/AN/AN/A
Dorthe RonnauSenior Vice President of People & CultureN/AN/A1966
Mr. Alain MorvanSenior Vice President of Sales EuropeN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.


Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Corporate governance

Coloplast A/S’s ISS governance QualityScore as of 1 April 2024 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.